Guide

Appealing a GLP-1 Denial: The Four Levels and What Wins at Each

A first-level denial is a routine administrative outcome, not a final answer, and denials that were documentary rather than clinical are frequently overturned. There are

Get the denial reason in writing first

Before anything else, obtain the written denial with the specific reason and the criterion it failed. Plans are required to provide this. Everything that follows depends on knowing whether you are arguing about a missing document or a clinical judgement, and those are entirely different appeals.

If the reason is vague — "not medically necessary" with no criterion cited — request the specific criterion applied and the clinical rationale. A denial that cannot name what it failed is itself a point on appeal.

The four levels

1. Internal appeal, first level. Your plan reviews its own decision. Most denials are resolved here when the original submission simply lacked an element. Deadlines to file are typically measured in months from the denial date and are stated in the letter.

2. Internal appeal, second level. A different reviewer within the plan, often with a clinician involved. Worth requesting a peer-to-peer review at this stage — your prescriber speaking directly to the plan's medical reviewer resolves clinical disagreements faster than correspondence.

3. External review. An independent organisation with no financial relationship to your plan reviews the decision. In most circumstances this determination binds the plan. This is the level most people never reach, and it is the one where the incentive structure is genuinely different.

4. Regulatory complaint. Your state insurance department for state-regulated plans, or the Department of Labor for self-funded employer plans. This does not replace the appeal but can move a plan that is missing its own deadlines.

What actually wins

Matching the criterion exactly. If the denial says a six-month documented lifestyle intervention was absent, the appeal supplies dated records covering it. Not an assertion that it happened — the records.

A letter of medical necessity that addresses the criteria in order. The most effective ones take each criterion the plan applied and answer it specifically, rather than making a general case.

Contraindication to the step-therapy drug. Where a preferred alternative is required but is contraindicated or was tried and failed, that documented fact usually resolves it.

A qualifying comorbidity that changes the indication. Approved indications now exist beyond weight management — obstructive sleep apnoea, cardiovascular risk reduction, heart failure with preserved ejection fraction. If one applies to you and was not raised, the picture may change entirely.

What does not work

Volume. A longer letter is not a stronger one, and reviewers work through criteria.

Restating the original submission. If it failed once it will fail again unless something is added.

Arguing the drug is effective in general. That is not in dispute; the criteria are.

And nothing that misrepresents your history. Beyond being dishonest, it is fraud, and it puts your prescriber's licence at risk alongside your coverage.

Keep the file

Every letter, every call with a date and reference number, every submission. Appeals turn on documented timelines — both yours and the plan's — and a plan that misses its own deadline has given you something.

While you appeal

Appeals take weeks. If you are mid-titration, discuss continuity with your prescriber rather than stopping — SURMOUNT-4 found participants withdrawn from tirzepatide regained 14% of body weight over the following year. Manufacturer bridge programmes and samples sometimes cover a gap; ask.

If you turn to a self-pay route in the meantime, our cheapest tirzepatide comparison sets out what each route costs at a maintenance dose rather than at signup.

Questions readers actually ask